104 related articles for article (PubMed ID: 2976106)
1. Analgesic activity of two synthetic immunomodulators, muramyl dipeptide and adamantylamide dipeptide in mice and rats.
Horák P; Masek K
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):569-74. PubMed ID: 2976106
[TBL] [Abstract][Full Text] [Related]
2. Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan.
Vacek A; Hofer M; Masek K
Immunopharmacol Immunotoxicol; 1999 Feb; 21(1):1-14. PubMed ID: 10084327
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulators levamisole, muramyl dipeptide and adamantylamide dipeptide antagonize the antianxiety effect of diazepam.
Sulcová A; Gulda O
Act Nerv Super (Praha); 1989 Jun; 31(2):111-3. PubMed ID: 2572130
[No Abstract] [Full Text] [Related]
4. Behavioural effects of muramyl dipeptide and adamantylamide dipeptide in mice.
Sulcová A; Krsiak M; Masek K; Gulda O
Act Nerv Super (Praha); 1989 Jun; 31(2):127-9. PubMed ID: 2800947
[No Abstract] [Full Text] [Related]
5. The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide.
Masek K; Seifert J; Flegel M; Krojidlo M; Kolínsky J
Methods Find Exp Clin Pharmacol; 1984 Nov; 6(11):667-9. PubMed ID: 6530904
[TBL] [Abstract][Full Text] [Related]
6. The effect of some immunomodulators administration to rats on palmitic and oleic acids incorporation into the lipids of liver cell organelles.
Buchar E; Farghali H; Janků I; Masek K
Methods Find Exp Clin Pharmacol; 1991 May; 13(4):269-71. PubMed ID: 1875776
[TBL] [Abstract][Full Text] [Related]
7. A long-form alpha-neurotoxin from cobra venom produces potent opioid-independent analgesia.
Chen ZX; Zhang HL; Gu ZL; Chen BW; Han R; Reid PF; Raymond LN; Qin ZH
Acta Pharmacol Sin; 2006 Apr; 27(4):402-8. PubMed ID: 16539838
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Walder P; Buchar E; Machková Z; Vrba T; Flegel M; Janků I; Masek K
Immunopharmacol Immunotoxicol; 1991; 13(1-2):101-19. PubMed ID: 1770213
[TBL] [Abstract][Full Text] [Related]
9. Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice.
Becker PD; Corral RS; Guzmán CA; Grinstein S
Vaccine; 2001 Sep; 19(32):4603-9. PubMed ID: 11535307
[TBL] [Abstract][Full Text] [Related]
10. Restoration of femoral GM-CFC progenitors in sublethally irradiated mice of various ages treated with liposomal adamantylamide dipeptide.
Kasná A; Turánek J; Vacek A; Záluská D; Knötigová P; Masek K
Int Immunopharmacol; 2004 Aug; 4(8):1099-106. PubMed ID: 15222985
[TBL] [Abstract][Full Text] [Related]
11. Antinociception produced by oral, subcutaneous or intrathecal administration of SC-39566, an opioid dipeptide arylalkylamide, in the rodent.
Hammond DL; Stapelfeld A; Drower EJ; Savage MA; Tam L; Mazur RH
J Pharmacol Exp Ther; 1994 Feb; 268(2):607-15. PubMed ID: 8113971
[TBL] [Abstract][Full Text] [Related]
12. Muramyl dipeptide and IL-1 effects on sleep and brain temperature after inhibition of serotonin synthesis.
Imeri L; Bianchi S; Mancia M
Am J Physiol; 1997 Nov; 273(5):R1663-8. PubMed ID: 9374807
[TBL] [Abstract][Full Text] [Related]
13. Edemagenic activity of aqueous form of muramyl dipeptide (MDP) in rats.
Zídek Z; Masek K
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):419-26. PubMed ID: 4079592
[TBL] [Abstract][Full Text] [Related]
14. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
Reisser D; Jeannin JF; Lagadec P; Martin F
J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
[TBL] [Abstract][Full Text] [Related]
15. Acute toxicity of muroctasin in mice, rats and dogs.
Ono Y; Iwasaki T; Furuhama K; Onodera T
Arzneimittelforschung; 1988 Jul; 38(7A):1022-4. PubMed ID: 3190794
[TBL] [Abstract][Full Text] [Related]
16. [The pharmacologic effect of flupirtine, a structurally new analgesic].
Jakovlev V; Sofia RD; Achterrath-Tuckermann U; von Schlichtegroll A; Thiemer K
Arzneimittelforschung; 1985; 35(1):30-43. PubMed ID: 2985093
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory properties of new conjugates of muramyl dipeptide and nor-muramyl dipeptide with retro-tuftsin (Arg-Pro-Lys-Thr-OMe).
Wardowska A; Dzierzbicka K; Trzonkowski P; Myśliwski A
Int Immunopharmacol; 2006 Oct; 6(10):1560-8. PubMed ID: 16919828
[TBL] [Abstract][Full Text] [Related]
18. T-cell-dependent immunobiological activity of a desmuramyl analog of muramyl dipeptide, adamantylamide dipeptide (AdDP), and D-isoglutamine.
Zídek Z; Masek K; Franková D; Flegel M
Int J Immunopharmacol; 1993 Jul; 15(5):631-7. PubMed ID: 8375945
[TBL] [Abstract][Full Text] [Related]
19. Muramyl dipeptide and sleep in rat.
Kadlecová O; Masek K
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):111-5. PubMed ID: 3713371
[TBL] [Abstract][Full Text] [Related]
20. The protection from hepatotoxicity of some compounds by the synthetic immunomodulator muramyl dipeptide (MDP) in rat hepatocytes and in vivo.
Farghali H; Machková Z; Kameníková L; Jankü I; Masek K
Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):449-54. PubMed ID: 6492941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
